Clinical Trials Browser

Phase 1/2 × HR-positive, HER2-negative Advanced Breast Cancer × Clear all

NCT06950086 2025-04-29

Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

HR-positive, HER2-negative Advanced Breast Cancer